ROYAL BANK OF CANADA

Bank

Position in ZTS — Zoetis Inc.

CIK 1000275 TORONTO, A6

Back to ZTS Full portfolio

Position in ZTS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$131,383,499

-$101,996,605 QoQ

Shares Held

1,828,326

-7.4% QoQ

Ownership

0.442%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#41

of 1,412 holders

Holding Since

Mar 2020

26 quarters on record

Voting authority Sole 99% Shared 0% None 1%

Common Shares in ZTS Over Time

Shares Held

Position Value (USD)

Derivatives in ZTS

reported options exposure · as of Jun 30, 2026

CallValue

$3,564,256

CallShares

49,600

PutValue

$3,046,864

PutShares

42,400

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

ROYAL BANK OF CANADA holds $624,876,791 across 66 Drug Manufacturers - Specialty & Generic names. ZTS ranks #2 (21.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RDY	Dr Reddys Laboratories Ltd	9,213,269	$133,500,266
2	ZTS	Zoetis Inc. This page	1,828,326	$131,383,499
3	NBIX	Neurocrine Biosciences Inc	583,476	$98,339,041
4	BHC	Bausch Health Companies Inc.	10,832,582	$53,404,627
5	VTRS	Viatris Inc	3,135,460	$49,791,098
6	UTHR	UNITED THERAPEUTICS Corp	62,600	$33,918,552
7	TEVA	Teva Pharmaceutical Industries Ltd	953,413	$32,301,629
8	HLN	Haleon plc	3,385,489	$31,586,609

All Filings in ZTS

Export CSV

32 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$131,383,499	1,828,326	-7.4%	Shares	Defined	2026-08-14
2026-06-30	$3,564,256	49,600	+230.7%	Call	Sole	2026-08-14
2026-06-30	$3,046,864	42,400	-58.4%	Put	Defined	2026-08-14
2026-03-31	$233,380,104	1,974,284	+20.8%	Shares	Defined	2026-05-15
2026-03-31	$12,045,599	101,900	+52.1%	Put	Defined	2026-05-15
2025-12-31	$205,677,697	1,634,698	-33.4%	Shares	Defined	2026-02-17
2025-12-31	$8,429,940	67,000	—	Put	Sole	2026-02-17
2025-09-30	$359,400,544	2,456,264	-14.8%	Shares	Defined	2025-11-14
2025-06-30	$449,655,930	2,883,334	-11.3%	Shares	Defined	2025-11-21
2025-03-31	$535,042,189	3,249,573	-5.5%	Shares	Defined	2025-11-21
2024-12-31	$560,136,228	3,437,895	+11.8%	Shares	Defined	2025-02-14
2024-09-30	$600,608,275	3,074,052	+2.4%	Shares	Defined	2024-11-14
2024-06-30	$520,176,036	3,000,554	-2.1%	Shares	Defined	2024-11-06
2024-03-31	$518,671,792	3,065,255	+1.5%	Shares	Defined	2024-11-05
2023-12-31	$595,824,891	3,018,822	-0.3%	Shares	Defined	2024-02-14
2023-09-30	$526,553,595	3,026,518	+3.1%	Shares	Defined	2023-11-14
2023-06-30	$505,402,764	2,934,805	-9.9%	Shares	Defined	2023-08-14
2023-03-31	$542,339,239	3,258,467	-2.0%	Shares	Defined	2023-05-15
2022-12-31	$487,395,251	3,325,795	-1.1%	Shares	Defined	2023-02-14
2022-09-30	$498,626,749	3,362,511	+1.3%	Shares	Defined	2022-11-14
2022-06-30	$570,524,217	3,319,124	-3.7%	Shares	Defined	2022-08-15
2022-03-31	$649,831,910	3,445,739	-16.2%	Shares	Defined	2022-05-16
2021-12-31	$1,003,271,014	4,111,261	+4.7%	Shares	Defined	2022-02-14
2021-09-30	$762,675,102	3,928,480	-3.7%	Shares	Defined	2021-11-15
2021-06-30	$760,211,818	4,079,265	+3.3%	Shares	Defined	2021-08-16
2021-03-31	$2,362,200	15,000	0.0%	Call	Defined	2021-07-20
2021-03-31	$622,172,294	3,950,802	+7.4%	Shares	Defined	2021-07-20
2020-12-31	$608,730,346	3,678,129	+6.7%	Shares	Defined	2021-02-16
2020-12-31	$2,482,500	15,000	—	Call	Defined	2021-02-16
2020-09-30	$570,120,344	3,447,544	+14.1%	Shares	Defined	2020-11-16
2020-06-30	$414,157,212	3,022,163	-3.7%	Shares	Defined	2020-08-14
2020-03-31	$369,373,472	3,138,529	—	Shares	Defined	2020-06-16
No filing history on record for this holder in this stock.